ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy.

Ji Young Yoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.